News | Cardiovascular Ultrasound | September 04, 2019

Global Echocardiography Normal Values Study Presented at European Society of Cardiology Congress

WASE Normal Values Study data focuses on defining normal values of 2-D left ventricular dimensions, volume and function across different races and nations

Global Echocardiography Normal Values Study Presented at European Society of Cardiology Congress

September 4, 2019 — Final data from the World Alliance Societies of Echocardiography (WASE) Normal Values Study was presented as part of the late-breaking science at the European Society of Cardiology (ESC) Congress, Aug. 31-Sept. 4 in Paris, France. The data presented focuses specifically on 2-D left ventricular dimensions, volumes and function. 

The WASE Normal Values Study, which was launched in 2016, is unique in that it provides normal reference values of echocardiographic parameters in adults across a wide range of age, race and ethnicity from 15 different countries. In contrast to previous studies, WASE included head-to-head inter-country and inter-race comparisons, in which all technical differences in data acquisition between regions were minimized and standardized by using state-of-the-art equipment and strictly following the 2015 ASE and European Association of Cardiovascular Imaging (EACVI) updated recommendations for chamber quantification. In addition, data analysis and interpretation were conducted uniformly by a core-laboratory at MedStar Health Research Institute and the University of Chicago.

Federico M. Asch, M.D., FASE, MedStar Health Research Institute, Washington, D.C., and Roberto M. Lang, M.D., FASE, University of Chicago, served as co-principal investigators on this study. Asch, who presented the data at ESC, said, “The clinical usefulness of echocardiography is based on the detection of abnormalities, which relies on the accurate definition of “normality” across different countries or races. Currently, available echocardiographic ‘reference values’ that define ‘normality’ are mostly based on cross-sectional observations of Caucasians from the United States and Europe. The WASE study evaluated individuals from multiple countries and races with the aim of describing normative values that could be applied to the global community world-wide, and to determine differences and similarities among people from different countries and races. The current report focuses specifically on 2-D left ventricular dimensions, volumes, and function.”

In total, 2,008 subjects were enrolled in the study. The average age was 45, where 42.8 percent were of White race, 41.8 percent Asian and 9.7 percent Black. Results indicated that left ventricular (LV) dimensions and volumes are larger in males, while left ventricular ejection fraction (LVEF) and global longitudinal strain (GLS) are higher in females. Global WASE normal ranges for LV dimensions were similar to those in the ASE/EACVI guidelines, but the upper limits of normal for LV volumes and the lower limits of normal for LVEF were higher in WASE study participants in all countries. 

Significant inter-country variation was identified for all left ventricular parameters reflecting LV size (dimensions, mass and volumes) even after indexing to body surface area (BSA), with left ventricular end-diastolic volume and left ventricular global systolic function having the highest variation. The largest volumes were noted in Australia, while the smallest were measured in India for both genders. While there were no differences in LV size between individuals of White and Black race, the LV of Asians and Mixed (mostly Mexicans mix of White and native American) were smaller. However, within each race group, there were significant inter-country variations. This finding suggests that in addition to gender and BSA, specific country should be considered when evaluating LV volumes. Inter-country variation for LVEF and GLS was smaller, but still statistically significant.

In conclusion, this study points out that current guideline-recommended normal ranges for LV volumes and EF should be adjusted. Inter-country variability is significant for LV volumes and therefore nationality should be considered for defining ranges of normality. 

A manuscript reporting these findings has been accepted for publication in the Journal of the American Society of Echocardiography will be published online later this month.

For more information: www.escardio.org


Related Content

News | Cardiovascular Clinical Studies

Nov. 10, 2025 —Genomics, a science-led techbio company, has today announced new research that suggests polygenic risk ...

Home November 12, 2025
Home
News | Cardiovascular Clinical Studies

Oct. 21, 2025 – AskBio Inc., a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG ...

Home October 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 25, 2025 — Merck, known as MSD outside of the United States and Canada, has announced that new clinical trial and ...

Home August 25, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 18, 2025 — (Newswise) It’s often mistaken for a heart attack, but Takotsubo cardiomyopathy — previously known as ...

Home August 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 20, 2025 — A major international study published in Atherosclerosis* has found that routinely testing for ...

Home August 20, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 4, 2025 — Marea Therapeutics, Inc., a clinical-stage biotechnology company that develops next-generation medicines ...

Home August 04, 2025
Home
News | Cardiovascular Clinical Studies

July 16, 2025 — Medtronic has announced that the first patient has been enrolled in the PEripheral Onyx Liquid Embolic ...

Home July 22, 2025
Home
News | Cardiovascular Clinical Studies

June 11, 2025 — Bayer and the Broad Institute have have extended their research collaboration of 10 years by an ...

Home June 11, 2025
Home
News | Cardiovascular Clinical Studies

May 27, 2025 — Despite scientific advances in cardiovascular care, people in living in rural areas and other communities ...

Home May 27, 2025
Home
News | Cardiovascular Clinical Studies

May 20, 2025 — Shockwave Medical, Inc., part of Johnson & Johnson MedTechhas announced the 30-day primary endpoint ...

Home May 21, 2025
Home
Subscribe Now